Scientist looking forward

Research at Center Mock

The Deirdre Imus Environmental Health Center® (DIEHC) at Hackensack University Medical Center is one of the first hospital-based programs whose mission is to identify, control, and ultimately prevent toxic exposures in the environment that threaten our children's health. Our research explores everyday environmental exposures with the goal of improving public health, one child at a time.

Completed Studies

shutterstock_25823767

Environmental Chemicals in
Fetal Cord Blood and Maternal
Urine: 
A Pilot Study.

Girls_with_Book_Bag

Environmental Chemicals and
Estrogen Metabolites in
Children: A Pilot Study

lice_nadine_crop

Safety and Efficacy of a 100%
Dimethicone Pediculocide in
School-age Children

 

Autism_Blocks

Mapping Contaminants  with
Autism: A Public Health Pilot
in New Jersey 


   

 

Current Studies

Endocrine disruptors, obesity, and breast density among perimenopausal women

This collaborative pilot study between Georgetown Lombardi Cancer Center with The Deirdre Imus Environmental Health Center® and The Betty Torricelli Institute for Breast Care at HackensackUMC investigates the association of endocrine disrupting chemicals (EDCs) with breast density among women undergoing mammographic screening. Washington, DC, and New Jersey have almost identical rates of breast cancer (~130 per 100,000 women) which are higher than the average U.S. population rates (122 per 100,000). Increased knowledge on the role of estrogen (and progesterone) in breast carcinogenesis suggests that environmental exposures that mimic estrogen effects in vivo, such as, endocrine disrupting chemicals (EDCs) and other xenoestrogens, may be potential risk factors for breast cancer. It is believed that exposure to EDCs during certain exposure windows, such as in-utero or in the peri-menopausal period, is more important for etiologic studies than cumulative lifetime exposures. Some preliminary data also suggests that exposure to EDCs is associated with higher mammographic breast density, an intermediate biomarker of risk for breast cancer.

1
 
close (X)